Cargando…
Targeting Phosphodiesterases—Towards a Tailor-Made Approach in Multiple Sclerosis Treatment
Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS) characterized by heterogeneous clinical symptoms including gradual muscle weakness, fatigue, and cognitive impairment. The disease course of MS can be classified into a relapsing-remitting (RR) phase defin...
Autores principales: | Schepers, Melissa, Tiane, Assia, Paes, Dean, Sanchez, Selien, Rombaut, Ben, Piccart, Elisabeth, Rutten, Bart P. F., Brône, Bert, Hellings, Niels, Prickaerts, Jos, Vanmierlo, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667646/ https://www.ncbi.nlm.nih.gov/pubmed/31396231 http://dx.doi.org/10.3389/fimmu.2019.01727 |
Ejemplares similares
-
PDE inhibition in distinct cell types to reclaim the balance of synaptic plasticity
por: Rombaut, Ben, et al.
Publicado: (2021) -
From OPC to Oligodendrocyte: An Epigenetic Journey
por: Tiane, Assia, et al.
Publicado: (2019) -
Sphingosine-1-Phosphate Receptor Modulators and Oligodendroglial Cells: Beyond Immunomodulation
por: Roggeri, Alessandra, et al.
Publicado: (2020) -
DNA methylation regulates the expression of the negative transcriptional regulators ID2 and ID4 during OPC differentiation
por: Tiane, Assia, et al.
Publicado: (2021) -
A perspective on causality assessment in epigenetic research on neurodegenerative disorders
por: Koulousakis, Philippos, et al.
Publicado: (2022)